ARNA Financial Facts
Other: -1.07MNet loss per share allocable to common stockholders, diluted: -0.05
See Full Income Statement
Common stock: 24K
Total current assets: 134.87M
See Full Balance Sheet
Arena Pharmaceuticals, Inc. (ARNA) Earnings
|
Expand Research on ARNA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -6.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -7.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/4/21 |  |
Q321 | -$3.21 | -$2.53 | -$0.68 | N/A | $680K | N/A |  | | Details |
| 5/7/20 | |
Q120 | -$2.00 | -$2.28 | +$0.28 | $300K | $1.58M | N/A | | | Details |
| 2/23/22 | Q421 | -$2.54 | -$2.26 | -$0.28 | $54K | $660K | N/A | | | Details | |
| 8/5/21 | |
Q221 | -$2.04 | -$2.19 | +$0.15 | N/A | $900K | N/A | | | Details |
| 5/5/21 | |
Q121 | -$1.98 | -$2.16 | +$0.18 | $300K | $570K | N/A | | | Details |
| 8/5/20 | |
Q220 | -$1.61 | -$2.03 | +$0.42 | N/A | $1.47M | N/A | | | Details |
| 2/23/21 | |
Q420 | -$2.10 | -$1.85 | -$0.25 | $37K | $560K | N/A | | | Details |
| 2/26/20 | |
Q419 | -$1.76 | -$1.55 | -$0.21 | $3M | $1.74M | N/A | | | Details |
